International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Aug 12, 2020, after the close
10-Q filed Aug 12, 2020, 43 days after period end · 0001564590-20-039693
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $1.81M | $2.32M | $3.04M | $1.76M |
| Net Income | -$1.09M | -$648.00K | -$394.00K | $568.00K |
| EPS Diluted | -$0.14 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.09 |
| -$0.06 |
| -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
